Study record

Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects

Ramanjaneya M, Jerobin J, Bettahi I et al. · Clin Endocrinol (Oxf) · 2019

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

In women with PCOS and controls, intralipid infusion increased plasma MOTS-c, and the subsequent insulin infusion blunted this rise (significantly only in PCOS before training). Exercise training did not change circulating MOTS-c in either group.

Limitations

Sample size not given in the abstract; ELISA-based measurement; women only.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedWomen with PCOS and healthy controls undergoing intralipid or saline infusion with a hyperinsulinaemic-euglycaemic clamp, before and after exercise training
Populationwomen with polycystic ovary syndrome and healthy controls
DesignInfusion and clamp study with exercise intervention; MOTS-c measured
Sample size as reportedNot reported
Control grouphealthy controls; saline infusion
Route (data field only)Not reported
Endpoints measuredplasma MOTS-c (ELISA); response to intralipid infusion; response to insulin clamp; change after exercise training
Pathways measuredInsulin & glucose handling · Lipid metabolism
Research areasMetabolic · Reproductive · Exercise
Evidence tierB — Other human study
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Not reported
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.